SIVA-1 enhances acquired chemotherapeutic drug resistance of gastric cancer in vivo by regulating the ARF/MDM2/p53 pathway
- Type
- Retraction
- Notice date
- 11/14/2025 0:00
- Journal
- Heliyon
- Publisher
- Elsevier - Cell Press
- Notice DOI
- 10.1016/j.heliyon.2025.e44173
- Original paper DOI
- 10.1016/j.heliyon.2024.e24394
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Image
- Concerns/Issues about Methods
- Investigation by Journal/Publisher
- Objections by Author(s)
- Unreliable Results and/or Conclusions